BALANCE SHEETS (USD $)
|
Dec. 31, 2011
|
Sep. 30, 2011
|
---|---|---|
CURRENT ASSETS | ||
Cash | $ 5,493 | $ 12,602 |
Prepaid expenses | 0 | 396 |
TOTAL ASSETS | 5,493 | 12,998 |
CURRENT LIABILITIES | ||
Accounts payable and accrued liabilities | 36,717 | 36,513 |
Due to related parties | 35,000 | 35,000 |
TOTAL LIABILITIES | 71,717 | 71,513 |
CAPITAL STOCK | ||
Authorized: 100,000,000 non-voting preferred shares at $0.001 par value | 0 | 0 |
750,000,000 common shares at $0.001 par value Issued and outstanding: 34,112,065 common shares (September 30, 2011 - 34,112,065) | 34,112 | 34,112 |
ADDITIONAL PAID-IN CAPITAL | 7,123,633 | 7,123,633 |
ACCUMULATED OTHER COMPREHENSIVE LOSS | (10,968) | (10,352) |
DEFICIT ACCUMULATED DURING THE DEVELOPMENT STAGE | (7,213,001) | (7,205,908) |
Total Stockholders' Equity | (66,224) | (58,515) |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ 5,493 | $ 12,998 |
M5C256DFJR47Z]>M&]-S.#[Z0QWO_J;'\8X(:Y[#S1<$2U.^6J')& MX!%&-?7SPV.G6/B&HFQ@GW^Z95XX!1JL?S:IWZ8!#A8=.F)\&F'VK!9)]"98 MS.#M,X&G,P+K9Q,.H[?/PME0U->=*S1^-.Z[L1%CQD%(LNCYO7RP]5IX"H#Z MX*]?K"0XN*"*EQ4SA'GQ]U\09<",7\3EODC++6WO4]XKFD/))?*"=3\$#8&\ MO3!NUBC+8MSH!'B78S9O^(`C#:E?(O;KSZ]6P^A'^>C3\O6/,,;JK31X0%-( M,*PEBS,8![3)MYE%W%MW*7^-T+S0VOR*HC%#7/97]R:8^.O6(\ZF)12X9H+E MR%`+A>2&S51#1"YJC/O`EU/R2?2_%F0@N\W0^]:?'=/WMFC9>GYQ:CWW@&,F M9?!O49"G\&TZ1S6?$#8;@NM30="4+/F*K3N"QAFJW_Z[8RI/")>MZI>G4O62 M[99DAR/2D6OIT^^PT$[K23K'5*\1-AN"GTX%02OD2M`[+#Q$_@>(Z^<<+:EC M0.A%SL;BYQ,/!S:=,MH/F/=G?R*%%]TP4/ZUBKKT8R.OD6/XF*@A&ZE_GQ8I M%>#REK2<,>/Z:6N;RDDL$H)F*__5B8?) 7U:7/Y@))1*Y$NCT0.2I',2B92PFC#M^6DQ^`B$_$[99]H')!@%OR-$ M"%R+A8[>24RTPFNP.7D,O7$\[N23K!&BHW0,#ZW`&B1.'F4O&5N&GV98Q&F= M1F-+:`T>7T+N7QJ9V="#I'MOFO?-AU:[_Z[='O1WS>MN=W*J!.[V6_ _S[I9ZTW$>L!S)$@HBR*NQ['&8(^^VG&5`!*Q5I ML,ZF=05;C:1'VM[:=V+,G0GMT'GQU)>GW;(CA06(5#I2[C$:8H(##$7^0A:E M$TY#IHC6#9`8EV;N0TZ#BF')L2D-+O9[$TW/8Z%<-7MHH4(#N9S*)SR4XSPE MA6Z2*]/0`:+$&E5&,=L+`4;'F"VSP[%D^'%N%@ M./^=E4L1[>5.&)$2"!5O!(N"E2RG@1,.1I[`!RQRRB[Y;#5[G4'SOC_HMG[/ M*?',)*M M7C>8`)=6)'4Z`2KP'#K48U.X9T(\0-`=#="3/H`IU8L+$)95S)$*:?<(7V`. MA,V4CR*=E3&T:0!\QK&`6QAA#P +I*WJ="Y_BT2/UC;$L;.8`LL6BZ^N!]\3Y9*4OO>9C^V'PKCWH MM*1E((D^BRDK*8!`\53GP#CJB0!B9%%KW(+"<08`^16RP\PD3("[6E2HYT$Q:.H&9 MD0JL2PRE#M\5CJ^\%JX!93JR*DSOI+B-#KD8@[.B=A.8M:C6Y5=*G-PU:N(F M/`;G='\^Q<&2_J`Y:+^7P6>_>]?MM1^;@T[W8>?`6M/;J6)JS>NKL?-'F`,- M"Z/E%%G5,9<[P;!.P]]BW6^Q[@X#M6"`6J/MW(5F(XQU>N[.@"-U$G]5;E\T M,^KIG4`B1USK0M"F__]0!-&Y5\:;4W5APM^11K5U!SKZBJ$IM+'M$@2MU`<< M/)K",T9%2!2G=Y":>C((7-!KEES6F7I'[5"%:":`P\2>6"^K426I LDIDS;$6#`VY6ZCH9+8R;1)2O+SX5^TEQ^Y-&(`WH8RPL6XGW;"Q2]"9 MZL.Z5,LC6R`2+/*GN@212\`DY3O2S72[`R#]"L!CNCP9XBUB&[>_(4Q5<=P- M2%,"?=E@F1Y<@JZ49HYTC]T>H 0RI;U2+?;[0[) M;T"E4$2=G_.GF$;70@=X#OF37U$KEX`JU,"1;K[;9X^:C4"(B)^,,$A+YA(J M:1F/=?O=/ADP`5)\=,20@72'^M"O#VR-23J'/QH*^D&"?#C MDW,^;H:-70+05!_'NE#O`"G1S6F)HF1HC-*M-&A<1'U&PKF"\P=&V;:(*WLK MR&X7MW,"7@/QK 5RW+YI-[")`.KD/F$3/WHU8Q]Q=VD<$NB.5G"0$O"!$1#JP4I#4R1GC9BX! M8:X+ZW+JBNTNCS,>51MU:#\<"NQCE+I\OTQ+ET`LI1'K%J>-FW0G5=!B5,H< M2K%7?A2CJ\38DFZ`GD"\QY3QZ'KCY99"E*&.][(\__4>@@GS-_L0NA7OE!PX MX>.<%!+])H)SKO'MBMTO>ED-VAN@,,+:&Z(*6CEA,H6B6[=5\0!!81"Z3>,$ M$`FQCG8"]O2`M1&G2 MM>9<+AEC>`BG0^#2(4G6@D>2:*`KUX<30)942\$&QJGJY%O-_KN[^^['@Y3) M;SJKHDI^\W8WJ\Z_%6I_187: IA M`EM>]8`=9E0>Y55G82''`<&ZTNQX"7YWU/3^"K&([@AL,:'_^D%^HZJ_BG#$ MX;-E(06JLV]>\3P.!M4*2;*O!<^4>JP;K>J`.:+>.JTNP^^/B',D-7/'>!_X M''LRAN,M@K#652[7QU>"?4G%'OV.[(B+HMW8',(SARU/1?K=)><^"A6)V(U$ MZ1%4,&UKB,_<$HI4=;BMG SP'?_E)KW=`?+DT?="?IC1J^Y5@;ZA(Z\Z\).MB4L4479[>U`;M MP8L=>_M*C&1G91]PYRO;&UP7,)0J%#-H=.;`FJK.NC,Z4GX.2-WHOOP9DWCU MR8:"M%Z)#L[`&M*,=;E MX=),;W\3UQC+1+,S0S*IE,-]<*[R4"XMK,DG*8WMPJBS,[,6,P4>[A"4A394 M^L.@I;HX,WLI_S%1)U.(YINA>]=M5&TAA]GW+:.P "_-Y(%U&88=S^&UUY.XP1=0[@".7UY'+CERN@JR;#>)K58M)DY8![)#( M\':HG>1S6M@YW@U,5K=\IU1BM6^V*3Z+?;+$`,;L=F<'ID8]]OE@,9YCB:6% MX:!,-3D[(--*L6Y>-1=Z[U7S//`MH[`S\K+:HQ%X@8P0G[P)HF-XE(;=I4H3 M,HQ0/U0H,9=!I#ZZ+M6%$YY5.:58=PM,-J,]X%A%_]O[!QI,2W7A!*;EE')& M%ZED"]Z4LQWG"SFQ11_*+&4&R;8.XY]2@[YTMB3PL\BR)&\\.&_X/UV=D0%( M88YWS !_F-T@/I-'<$'WV MX."OJ?K*ZD/:T]8-R@?'0Y^!VK.F1#\]KOZB_AE*]TP^^0=02P,$%`````@` MC7F^0!@E+M4[!```&!<``!$`'`!U<&)S+3(P,3$Q,C,Q+GAS9%54"0`#&G'& M3QIQQD]U>`L``00E#@``!#D!``#M6%USVC@4?>[.['_0\N(G8QR23F$@'8=" MPY0"@]GIOF6$+8BFLN25Y";Y]WOE#S`$7*=-9C([R4MDW7,_C@Z^]G7OXWW$ MT`\B%16\;[G-EH4(#T1(^:9O427L#Q\N.K9K?;S\\X_>7[:-ID0,&):)0C:B M(\H(\A.J21$#M9OGY^USA&S;>*C@ED0801*NNB&A?>M6Z[CK./ 6&Z"F.B(IQ0.HD32O<`]ZUFT)N M`-)RG7^^3OR4>$'EGE'^_1C<[70Z3FHMH(^0Z4GEH=N.,:^P(MO(8*45>,J5 MQCS8PX=Z7X8.%DQ@*:*'N#<;S%KK%:I=C<4)8,M'[7PYP+C37\"LPE7, "_>T6Z5%4=# M>>,OO>7PZW"Z]&>C@>=?CR:S;WX#T;#?.&W.DN?9=[^_RQ;\7;3@*>##'9;V M5[/>AD"S$3)!4!JEYQRZEZ,FBH0S?IFN#V_:W#.'G/+:OR_J^1S(=<0IWRJ. M_"5DF,V'"V\YGDU/Z%"R5PEQ7BW$+LJ;$"4AKKR)-QT,_>OA<%DZ__WMJF,_ M.SSVW!5EOF^'73KL3R)(S"D5_ST>#KFF^F$,[P@R2BO::5`+726-:Z0IO,M+ MS$.4A4*E6&]2E:6B*F!")9)<>?X8NM!\,?2AEZ0MI*11):Q*G/>I.%OW],:! M"*95E6.\B7*J6D=]_72G_H_SL5"#[]W2($MW^YD-(L:PJX.)7ZZ/!;)UOJ M>'0<=@C3JMBQ=P/RJ1*J9FI4NY3#[RAF42-YY3>8+'G^Y01QRF!2@^G%TC(Q M'Q/,9X KXJ@275B=G]+$42%R51*.:EZ0V\^7@)C7(Y&WSY&9WC MV& YSEAY($CY/[9\Q MY1.AU(S[F)'9>LPU88P$.L%LG@W=#P6C>MA7*9$I>R1%]'.2=9"ODJ*O1?#] M"L.3?2"BF'"5>V>T3EEK4.DY69.%Y7]02P$"'@,4````"`"->;Y`[KTYR4X2 M``#9A0``$0`8```````!````I($`````=7!B `L``00E#@``!#D!``!02P$"'@,4````"`"->;Y`M3%D+P,"```" M"@``%0`8```````!````I(&9$@``=7!B &UL550% M``,:<<9/=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`C7F^0)O]IEY;"P`` M8Z(``!4`&````````0```*2!ZQ0``'5P8G,M,C`Q,3$R,S%?9&5F+GAM;%54 M!0`#&G'&3W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`(UYOD`!8E?>,1<` M`!(.`0`5`!@```````$```"D@94@``!U<&)S+3(P,3$Q,C,Q7VQA8BYX;6Q5 M5`4``QIQQD]U>`L``00E#@``!#D!``!02P$"'@,4````"`"->;Y`\$7H1RX- M```XP0``%0`8```````!````I($5.```=7!B &UL M550%``,:<<9/=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`C7F^0!@E+M4[ M!```&!<``!$`&````````0```*2!DD4``'5P8G,M,C`Q,3$R,S$N>'-D550% K``,:<<9/=7@+``$$)0X```0Y`0``4$L%!@`````&``8`&@(``!A*```````` ` end XML 14 R6.htm IDEA: XBRL DOCUMENT
BASIS OF PRESENTATION3 Months Ended Dec. 31, 2011BASIS OF PRESENTATION BASIS OF PRESENTATION 1. BASIS OF PRESENTATIONThese unaudited financial statements of Upstream Biosciences Inc. (the"Company") have been prepared in accordance with generally accepted accountingprinciples in the United States of America for interim financial statements andthe rules and regulations of the Securities and Exchange Commission. They do notinclude all information and footnotes required by United States generallyaccepted accounting principles for complete financial statement disclosure.However, except as disclosed herein, there have been no material changes in theinformation contained in the notes to the audited financial statements for theyear ended September 30, 2011, included in the Company's Form 10-K filed withthe Securities and Exchange Commission. These interim unaudited financialstatements should be read in conjunction with the audited financial statementsincluded in the Form 10-K. In the opinion of management, all adjustmentsconsidered necessary for fair presentation, consisting solely of normalrecurring adjustments, have been made. Operating results for the three monthsended December 31, 2011, are not necessarily indicative of the results that maybe expected for the year ending September 30, 2012.Going concernThese unaudited financial statements have been prepared on a going concernbasis, which contemplates the realization of assets and the satisfaction ofliabilities and commitments in the normal course of business. As at December 31,2011, the Company has a working capital deficiency of $66,224 and has incurredlosses since inception of $7,115,301. This raises substantial doubt about theCompany's ability to continue as a going concern which is dependent upongenerating profitable operations and obtaining the necessary financing to meetits obligations when they become due. There is no assurance that equity or debtcapital will be available as necessary to meet the Company's requirements or, ifthe capital is available, that it will be on terms acceptable to the Company.Recent Accounting PronouncementsThe Company has reviewed recently issued accounting pronouncements and plans toadopt those that are applicable to it. It does not expect the adoption of thesepronouncements to have a material impact on its current financial position,results of operations or cash flows.XML 15 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details '+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = ""+ text.join( "
"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "
\n" ) +"" + text[p] + "
\n"; } } }else{ formatted = '' + raw + '
'; } html = ''+ "\n"+''+ "\n"+'Report Preview Details '+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+''+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }'+ "\n"+' '+ "\n"+''+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+' '+ "\n"+''+ "\n"+' '+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+''+ "\n"+' '+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+'XML 16 R3.htm IDEA: XBRL DOCUMENT
BALANCE SHEETS PARENTHETICALS (USD $) Dec. 31, 2011 Sep. 30, 2011Preferred Stock, par value $ 0.001 $ 0.001 Preferred Stock, shares authorized 100,000,000 100,000,000 Common stock, par value $ 0.001 $ 0.001 Common stock, shares authorized 750,000,000 750,000,000 Common Stock, shares issued 34,112,065 34,112,065 Common Stock, shares outstanding 34,112,065 34,112,065 XML 17 R1.htm IDEA: XBRL DOCUMENT
Document and Entity Information3 Months Ended Dec. 31, 2011 Feb. 14, 2012Document and Entity Information Entity Registrant Name UPSTREAM BIOSCIENCES INC. Document Type 10-Q Document Period End Date Dec. 31, 2011 Amendment Flag false Entity Central Index Key 0001174891 Current Fiscal Year End Date --09-30 Entity Common Stock, Shares Outstanding 34,112,065 Entity Filer Category Smaller Reporting Company Entity Current Reporting Status Yes Entity Voluntary Filers No Entity Well-known Seasoned Issuer No Document Fiscal Year Focus 2012 Document Fiscal Period Focus Q1 XML 18 R4.htm IDEA: XBRL DOCUMENT XML 19 R5.htm IDEA: XBRL DOCUMENT XML 20 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 9 81 1 false 0 0 false 3 false false R1.htm 000010 - Document - Document and Entity Information Sheet http://www.upstream.com/20111231/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information true false R2.htm 000020 - Statement - BALANCE SHEETS Sheet http://www.upstream.com/20111231/role/idr_BALANCESHEETS BALANCE SHEETS false false R3.htm 000030 - Statement - BALANCE SHEETS PARENTHETICALS Sheet http://www.upstream.com/20111231/role/idr_BALANCESHEETSPARENTHETICALS BALANCE SHEETS PARENTHETICALS false false R4.htm 000040 - Statement - STATEMENTS OF OPERATIONS Sheet http://www.upstream.com/20111231/role/idr_STATEMENTSOFOPERATIONS STATEMENTS OF OPERATIONS false false R5.htm 000050 - Statement - STATEMENTS OF CASH FLOWS Sheet http://www.upstream.com/20111231/role/idr_STATEMENTSOFCASHFLOWS STATEMENTS OF CASH FLOWS false false R6.htm 000060 - Disclosure - BASIS OF PRESENTATION Sheet http://www.upstream.com/20111231/role/idr_DisclosureBASISOFPRESENTATION BASIS OF PRESENTATION false false All Reports Book All Reports Process Flow-Through: 000020 - Statement - BALANCE SHEETS Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: Removing column 'Sep. 30, 2010' Process Flow-Through: Removing column 'Jun. 13, 2004' Process Flow-Through: 000030 - Statement - BALANCE SHEETS PARENTHETICALS Process Flow-Through: 000040 - Statement - STATEMENTS OF OPERATIONS Process Flow-Through: 000050 - Statement - STATEMENTS OF CASH FLOWS upbs-20111231.xml upbs-20111231.xsd upbs-20111231_cal.xml upbs-20111231_def.xml upbs-20111231_lab.xml upbs-20111231_pre.xml true true